An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer

por Guo, Xiao-Fang, Zhu, Xiao-Fei, Yang, Wan-Cai, Zhang, Sheng-Hua, Zhen, Yong-Su
Publicado 2014

Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy

por ZHONG, GEN-SHEN, WU, MIN-NA, GUO, XIAO-FANG, XU, ZHI-SHAN, ZHANG, SHENG-HUA, ZHEN, YONG-SU
Publicado 2013

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy

por Xu, Jian, Liu, Xiu-Jun, Li, Liang, Zhang, Sheng-Hua, Li, Yi, Gao, Rui-Juan, Zhen, Yong-Su
Publicado 2015

A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer

por Du, Yue, Shang, Bo-yang, Sheng, Wei-jin, Zhang, Sheng-hua, Li, Yi, Miao, Qing-fang, Zhen, Yong-su
Publicado 2016

Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis

por Jiang, Wen-guo, Lu, Xin-an, Shang, Bo-yang, Fu, Yan, Zhang, Sheng-hua, Zhou, Daifu, Li, Liang, Li, Yi, Luo, Yongzhang, Zhen, Yong-su
Publicado 2013